THE NANOMAL PROJECT

 

The FP7 European Union funded NANOMAL PROJECT is developing a simple, rapid and affordable point-of-care (POC) handheld diagnostic device to confirm malaria diagnosis and detect drug resistance in malaria parasites in minutes and at the patient’s side, by analysis of mutations in malaria DNA using a range of proven nanotechnologies. ┬áThe device will be critical at many levels in malarial control by:

The Nanomal Consortium partners are St George’s, University of London, QuantuMDx Group, The Karolinska Insititute and Tubingen University.

LATEST NEWS